Meenaxi Research is a rapidly growing medical research company based in New Jersey. The startup specializes in Herbo Mineral technology to address skin diseases. It aims at facilitating its formulations for Atopic Dermatitis globally at extremely affordable prices. Mr. Kaushik Gandhi, the founder of Meenaxi Research Inc., is an expert in herbal and allopathic dermatological research. He began his career in Ayurveda Sciences. According to him, “A skin disease produces psychological problems that seriously affect patients’ lives in ways comparable to a disabling illness.”
Inkwood: How did the COVID-19 pandemic impact your company?
Mr. Kaushik Gandhi: Even though the COVID-19 pandemic has placed a tremendous strain in terms of sustenance of the medical research industry, Meenaxi Research was established in North America during the pandemic. The preliminary research and development of the drug, along with the initial clinical trial, had already taken place in India. The migration of the resources and initiation of the startup happened during these testing times. It was difficult, especially with the lockdown, but not impossible.
It would be safe to infer that the pandemic has had minimal impact on our business.
Inkwood: Is Atopic Dermatitis contagious?
Mr. Kaushik Gandhi: Atopic Dermatitis is a chronic inflammatory disease that affects the skin. It is not at all contagious. It is believed to be caused by a genetic defect, and environmental exposure often triggers it. It is not caused by bacteria or a virus, so it is not communicable via touching or being around a patient suffering from Atopic Dermatitis.
Inkwood: What are the products managed by your company to tackle the problem of Dermatitis?
Mr. Kaushik Gandhi: Our company specializes in the formulation of drugs for skin diseases by Herbo Mineral Technology. Its lotion for Atopic Dermatitis is developed and ready to undergo clinical trial in the US. The drugs in the developmental stage will focus on addressing the problems of Dandruff and Seborrheic Dermatitis. However, one of our biggest projects is a dietary supplement for Epilepsy.
Inkwood: Can Eczema lead to any other skin condition?
Mr. Kaushik Gandhi: Eczema does not lead to any other skin condition. People suffering from asthma often develop Eczema, but there is no proof that Eczema causes other skin conditions.
Inkwood: Is there a plan to expand the Company’s business in the near future?
Mr. Kaushik Gandhi: Our company was established with the view to eradicating the problem of Dermatitis globally. We aim at making our drug readily available to patients with Atopic Dermatitis all over the world. Our future plans include the expansion of the brand not just in North America but also in Asia, Europe, and Australia. We are constantly seeking opportunities and looking for partnerships and associations that would help us in our endeavor.
Inkwood: Are Prescription treatments available for severe Atopic Eczema?
Mr. Kaushik Gandhi: The market is flooded with topical steroids in various forms of salts in varying strengths and potencies. There are several over-the-counter and prescription drugs available in the market, but none of them have proven to be effective in providing long-term relief from Atopic Dermatitis. One of the most common limitations being the relapse of eczema on the stoppage of its use.
Inkwood: For how long do you instruct your Customers to use Herbo Mineral formulation to address eczema problems?
Mr. Kaushik Gandhi: Our drug is a lotion that can be applied to the affected area topically. It is packed with the goodness of some of the very effective drugs. As per our initial clinical trial in a renowned medical facility in India, the drug showed significant effects. It gave relief from the symptoms of atopic Dermatitis within 24 to 48 hours of its application.
Inkwood: Are there any possible side-effects of using Herbo Mineral formulation?
Mr. Kaushik Gandhi: Herbo-Mineral Technology is a nomenclature in modern Ayurvedic formulations. In Ayurveda, medicines are prepared by herbs and minerals. During preparations, various herbs are used in the Shodan process. These preparations fall within the category of herbo mineral preparations. In Ayurveda, it is known as Ras shastra.
The amalgamation of herbo mineral technology and modern medicine is found to be the most effective and efficient to treat the toughest of skin diseases. It has not shown any side-effects so far, which is an addition to its unique properties.
Inkwood: What are the most common causes of eczema?
Mr. Kaushik Gandhi: Eczema is related to a gene variation that affects the skin’s ability to provide protection. This allows the skin to be affected by irritants, allergens, and a combination of factors like dry skin, environmental setting, and bacteria on the skin. In some children, food allergies may play a role in causing eczema. For early-stage eczema, moisturizing is the key to attaining calm skin.
Inkwood: What led to the inception of Meenaxi Research?
Mr. Kaushik Gandhi: It was evident that a skin disease is not just a cosmetic nuisance but can produce anxiety, depression, and other psychological problems that affect patients’ lives in ways comparable to arthritis or other disabling illnesses. The market was flooded with topical steroids, but the disease reoccurred when the patient stopped using the product. Thus, the drug’s effectiveness was questionable. After years of research, I came up with a unique formulation using Herbo-Mineral Technology to treat eczema patients. Its clinical trial in a renowned medical facility produced a successful 98% result. The aim of perfecting and achieving the 100% mark motivated me to establish a medical research company dedicated to developing medicines for Atopic Dermatitis, Seborrheic Dermatitis, and Epilepsy.
Inkwood: What are the company’s aim and vision?
Mr. Kaushik Gandhi: Our company aims at being recognized as the finest medical research company in the world, known for its innovations and advancements in the healthcare industry. We are focused on developing products and processes of the highest quality. Our passion and commitment are the driving force behind the vision to facilitate healthy living. We are deeply committed towards the industry’s needs and satisfaction.
Inkwood: What are the long-term goals and aspirations of Meenaxi Research?
Mr. Kaushik Gandhi: Moving forward, our mission is to formulate various dermatological drugs to bring about a new paradigm in the industry. We are proactively in search of investors and partners to collaborate in working towards facilitating life-changing medicines to the market faster and inexpensively. We aspire to build a brand that is recognized for its comprehensive health management. Our company’s foundation lies in its diligent efforts to contribute to the enrichment of the quality of life around the world. It will be achieved through the creation of innovative drugs and the provision of affordable healthcare addressing diverse medical needs.
Inkwood: What are the company’s ongoing projects?
Mr. Kaushik Gandhi: Meenaxi Research’s priority is to develop drugs that will help in curing patients around the world. We are committed to formulating world-class solutions for skin diseases. The ongoing project in our laboratory is a revolutionary drug for Epilepsy. Our anti-epilepsy drug is in its developmental stage and is 100% safe and natural. It is unique because it ensures no side-effects. We are certain that it will change the dynamics of the medical industry and are excited to introduce it to the world in the near future.